Psychiatric News
February 16, 2023
Jacques Ambrose, Jeffrey S Zabinski
With the impending FDA review of the phase 3 data for MDMA-assisted psychotherapy for PTSD, experts reflect on ethical considerations, appropriate use, and access. The groundswell of interest in psychedelics in psychiatry, medicine broadly, and in popular culture continues without a peak in sight. Though the term “psychedelic” was coined in the 20th century, these compounds have an extensive...
Biomedicines
February 5, 2023
Erika Plazas, Nicoletta Faraone
40 citations
Neuropsychiatric diseases such as depression, anxiety, and post-traumatic stress represent a substantial long-term challenge for the global health systems because of their rising prevalence, uncertain neuropathology, and lack of effective pharmacological treatments. The approved existing studies constitute a piece of strong evidence whereby psychiatric drugs have shown to have unpleasant side...
Journal of Interprofessional Education & Practice
February 1, 2023
K. Wood, Carolanne Carini
Few career paths are as mentally, physically, and emotionally exhausting as a career in healthcare. Due to the nature of the job responsibilities, healthcare professionals often sacrifice their own wellbeing for the sake of their patients. The COVID-19 pandemic has asked an even greater sacrifice from healthcare professionals and continues today with little end in sight. The majority of...
Journal of Sleep Research
February 2023
Yaping Liu, Eemil Partinen, Ngan Yin Chan et al.
There has been increasing concern about the long-term impact of coronavirus disease 2019 (COVID-19) as evidenced by anecdotal case reports of acute-onset parkinsonism and the polysomnographic feature of increased rapid eye movement sleep electromyographic activity. This study aimed to determine the prevalence and correlates of dream-enactment behaviours, a hallmark of rapid eye movement sleep...
Journal of Police and Criminal Psychology
January 30, 2023
Tadas Vadvilavičius, Erika Varnagirytė, G. Jarašiūnaitė-Fedosejeva et al.
The profession of a police officer is associated with high levels of stress, which can have harmful consequences for officers’ personal lives, the police organisation, and society. This systematic review aims to synthesise recent literature on the effectiveness of mindfulness-based intervention related to stress reduction (MBIs) in a sample of police officers. The search of relevant articles...
Advances in Research
January 30, 2023
Jennings Hernandez
Roughly over 700 million individuals suffer from a mental illness globally. In the United States alone, over 45 million individuals are afflicted with a mental disorder at any given point in their lives. It is because of this that new methods of current therapies should be considered. To date, major depression disorder (MAD), anxiety, and post-traumatic stress disorder (PTSD) are treated with...
PNAS Nexus
January 23, 2023
Cody A Cushing, Alexei J Dawes, Stefan G Hofmann et al.
The mechanisms underlying the subjective experiences of mental disorders remain poorly understood. This is partly due to long-standing over-emphasis on behavioral and physiological symptoms and a de-emphasis of the patient's subjective experiences when searching for treatments. Here, we provide a new perspective on the subjective experience of mental disorders based on findings in neuroscience...
ACS Medicinal Chemistry Letters
January 18, 2023
Robert B. Kargbo
2 citations
The renaissance of research into psychedelics class of drugs has renewed interest for a possible psychedelic clinical therapy for treating psychiatric conditions such as treatment-resistant depression, major depressive-disorder, post-traumatic stress disorder, and other neuropsychiatric diseases. Psychedelics are known to stimulate neurogenesis and gliogenesis, reduce inflammation, and...
AIDASCO Reviews
January 17, 2023
Dragana Marković, Eleonora Čapelja
2 citations
Major depressive disorder (MDD), also known as clinical depression, is a serious mental disorder and ranks first among psychiatric disorders that dominate the global disease burden. Recently, it was found that psilocybin, active compound derived from psychotropic mushrooms, can relieve depression symptoms rapidly and sustained benefits for several months. Beside MDD, psilocybin can alleviate...
Journal of Psychedelic Studies
January 16, 2023
Mitch Earleywine, Philip Kamilar-Britt
AbstractPsychedelic compounds hold promise for alleviating human suffering. Initial trials of psychedelic-assisted treatments have established feasibility and safety, generating calls for replications. Meanwhile, social and medical sciences have drawn criticism due to perceptions of replication failures and varying public trust in empiricism. Data suggest that researchers and the public...